Alpha memo: resveratrol exercise cross-context evidence signal

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Reconcile or faithfully reproduce the rodent study's n and group structure (the source's own '64 rats / six groups' is itself inconsistent; flag the source-side inconsistency and report the figure most defensibly grounded in the excerpt, e.g., 64 rats allocated to six arms with the excerpt's breakdown).
2. Acknowledge Receipt 1's cross-factorial design (chronic training × acute bout × resveratrol) rather than presenting it as a clean three-arm comparison, so the mechanistic claim stays proportionate.
3. State Receipt 2's reported functional-fitness/body-composition/aerobic-capacity results to the extent available, or explicitly note they were not retrievable from the bundle; the current memo treats Receipt 2 as a gap-source without reporting its outcome, which weakens the cross-context contrast.
4. Optional: tighten the title to reflect the actual contrast (rodent inflammation mechanism vs. human T2DM functional-fitness trial) so readers do not expect a settled clinical signal.

Minor issues

• Receipt 1 description contains an internal inconsistency: '64 male Wistar rats across resveratrol/exercise/control arms' is then re-described as 'six groups, each group consisting of 16 animals' — 6×16=96, not 64. The source excerpt itself says 'Sixty-four male Wistar rats were divided into six groups', which is also inconsistent. The memo should report the source's own stated numbers faithfully without compounding the error.
• Receipt 1 reference to 'half of the mice in each group received acute exercise training' (excerpt) conflicts with the memo's framing of clean resveratrol/exercise/control arms; the memo simplifies away a cross-factorial design that the source actually describes. This should be acknowledged so the rodent signal is not overstated.
• The 'Why this is surprising' framing leans on a gap-based argument (Receipt 2 framed a needed evidence gap) rather than a substantive result contrast; the memo would be stronger if it stated what Receipt 2 actually found for functional fitness, not just that prior evidence in diabetics was limited.
• No injection or prompt-override artifacts detected in manuscript text.

Reviewer note

The memo attempts a bounded cross-context evidence map: rodent acute-exercise inflammation model vs. human T2DM functional-fitness trial, both under a resveratrol+exercise anchor. The one-sentence alpha appropriately hedges and the falsifier section is unusually concrete for a two-receipt artifact. Title/source alignment is acceptable — both receipts are genuinely resveratrol+exercise studies, and the memo explicitly frames this as a heterogeneous cross-context signal rather than a unified clinical claim, which is the right calibration given the source bundle. The main weaknesses are descriptive rather than structural. Receipt 1 is summarized with n/group numbers that do not reconcile (six groups × 16 = 96, not 64), and the memo flattens a cross-factorial chronic-training × acute-bout × resveratrol design into a simple three-arm comparison. These are not fatal — the mechanistic claim about IL-6 / inflammation remains proportionate — but they are fixable bounded edits. Receipt 2 is cited for its gap-framing language but its actual outcomes are not reported; the cross-context contrast would be sharper if even a one-line outcome statement were added or the omission explicitly flagged. No major issues, no injection artifacts, no overclaim of clinical or policy relevance. Scores are uniformly 3–4; the manuscript is salvageable with bounded edits, so revise is the correct call.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: fallback_tiebreak_failed_conservative

Prompt: reviewer-v11-research-synthesis